|
The Human Tumor Atlas Network (HTAN) – a Cancer Moonshot initiative – is working to produce molecular resolution-level, single-cell spatial atlases of cancers as they progress from precancer to locally invasive cancer, to metastatic and therapy-resistant stages. The Summer HTAN meeting will highlight the HTAN atlases currently available and include presentations from investigators outside HTAN who have employed HTAN data and resources in their own projects. Virtual participants will be able to ask questions and contribute to the meeting.
Registration is open until June 13, 2023.
|
The NCI Division of Cancer Prevention Immunology Interest Group (DCP-IIG) announces the launch of a new quarterly seminar series focused on cancer prevention, interception, and immuno-oncology. Join the upcoming inaugural seminar featuring Olivera J. Finn, Ph.D., University of Pittsburgh Distinguished Professor of Immunology and Surgery. Dr. Finn will speak on “Therapeutic and Preventative Cancer Vaccines: The Last 30 Years.”
Registration required
Current NCI grant awardees or cooperative agreement program participants can collaborate with the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Specialized Centers to support the CAP-IT Program research. Collaborations should be proposed by investigators, who are not currently CAP-IT Center investigators (non-CAP-IT investigators) and whose research scope, interests and activities as specified in the parent awards are within the CAP-IT Program’s research objectives. All potential applicants are encouraged to contact one of the NCI Program Directors to discuss the planned collaboration and application: Shizuko Sei, M.D., John Clifford, Ph.D., or Vignesh Gunasekharan, Ph.D.
|
Co-sponsored by the National Cancer Institute and the National Institute on Aging, this webinar series aims to facilitate the understanding of the complex roles that aging and comorbidities play in mechanisms underlying cancer response, cancer treatment, and survivorship. The speakers will explore the status, challenges, and opportunities in selected areas of high significance to cancer research in the context of aging and comorbidities. The topic for the June 15 webinar is “Food as a Drug.” Speakers are Lydia Lynch, Ph.D., Harvard Medical School, and Nicole Simone, M.D., Thomas Jefferson University.
Registration required
|
|
|
The workshop will have talks to set the stage and two scientific sessions focused on the basic and translational science related to serous endometrial cancer, followed by a breakout discussion session with the aim of finalizing the identified gaps in the field and potential research.
Registration is required by 5 p.m. ET on June 21, 2023
|
DCP is issuing a call for nominations to feature early career scientists conducting research within the mission of the Division. Individuals selected for this opportunity will be highlighted on the NCI DCP website and in social media led by the Division.
The NCI PREVENT Cancer Preclinical Drug Development Program (PREVENT) is a peer-reviewed program that supports the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations. All interested researchers with innovative ideas in precision cancer prevention are encouraged to apply.
|
|
|
|
|
